Abemaciclib and breast feeding
No information is available on the clinical use of abemaciclib during breastfeeding. Because abemaciclib and its metabolites are over 90% bound to plasma proteins, the amount in milk is likely to be low. However, the manufacturer recommends that breastfeeding be discontinued during abemaciclib therapy and for 3 weeks after the final dose.
Up to date info
Alternative drugs - Abemaciclib and breast feeding
Suggested alternatives on Abemaciclib and breast feeding, when available and appropriate.
Breast feeding and drugs